(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
3.03% $ 37.40
@ $36.93
Wydano: 14 vas. 2024 @ 22:32
Zwrot: 1.27%
Poprzedni sygnał: vas. 14 - 16:30
Poprzedni sygnał:
Zwrot: 3.50 %
Live Chart Being Loaded With Signals
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system...
Stats | |
---|---|
Dzisiejszy wolumen | 529 366 |
Średni wolumen | 639 964 |
Kapitalizacja rynkowa | 2.29B |
EPS | $0 ( 2024-05-02 ) |
Następna data zysków | ( $-0.730 ) 2024-06-18 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -14.84 |
ATR14 | $0.0450 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Baker Bros. Advisors Lp | Buy | 32 000 | Non-Qualified Stock Option (right to buy) |
2024-03-28 | Baker Bros. Advisors Lp | Buy | 0 | Common Stock |
2024-03-28 | Baker Bros. Advisors Lp | Buy | 0 | Common Stock |
2024-03-28 | Baker Bros. Advisors Lp | Buy | 7 379 066 | Prefunded Warrants |
2024-03-14 | Booth Bruce | Sell | 34 473 | Common Stock |
INSIDER POWER |
---|
44.21 |
Last 97 transactions |
Buy: 2 823 290 | Sell: 1 008 904 |
Wolumen Korelacja
Kymera Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
MRUS | 0.941 |
SLN | 0.938 |
SWTX | 0.937 |
YMAB | 0.936 |
IMNM | 0.935 |
TNYA | 0.933 |
SRTS | 0.93 |
EOLS | 0.927 |
REYN | 0.923 |
FWRG | 0.922 |
10 Najbardziej negatywne korelacje | |
---|---|
RTPY | -0.94 |
VALN | -0.934 |
RELL | -0.921 |
BFRI | -0.907 |
DSWL | -0.907 |
CNTY | -0.905 |
CRCT | -0.902 |
BSGM | -0.899 |
KVSB | -0.897 |
SVOK | -0.897 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kymera Therapeutics, Inc. Korelacja - Waluta/Towar
Kymera Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $78.59M |
Zysk brutto: | $75.03M (95.46 %) |
EPS: | $-2.52 |
FY | 2023 |
Przychody: | $78.59M |
Zysk brutto: | $75.03M (95.46 %) |
EPS: | $-2.52 |
FY | 2022 |
Przychody: | $46.83M |
Zysk brutto: | $43.85M (93.64 %) |
EPS: | $-2.82 |
FY | 2021 |
Przychody: | $72.83M |
Zysk brutto: | $72.83M (100.00 %) |
EPS: | $-1.976 |
Financial Reports:
No articles found.
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases and fibrosis; and MDM2 program to treat hematological malignancies and solid tumors. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej